You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 3, 2026

Patent: 9,499,625

✉ Email this page to a colleague

Summary for Patent: 9,499,625

98https://www.drugpatentwatch.com/inc/modules/tools/ai_gpt_report.php?dashboard=biologics§ion=patent&query=9%2C499%2C625&subsorpreview=preview

Title:	Antibodies against human CSF-1R and uses thereof
Abstract:	The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.
Inventor(s):	Nikolaos Dimoudis, Georg Fertig, Alexander Fidler, Klaus Kaluza, Marlene Thomas, Carola Ries, Stefan Seeber, Martin Lanzendoerfer
Assignee:	Roche Diagnostics GmbH , Hoffmann La Roche Inc
Application Number:	US14/640,183
Patent Claims:	see list of patent claims

Details for Patent 9,499,625

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	STELARA	ustekinumab	Injection	125261	September 25, 2009	9,499,625	2035-03-06
Janssen Biotech, Inc.	STELARA	ustekinumab	Injection	125261	December 30, 2009	9,499,625	2035-03-06
Novartis Pharmaceuticals Corporation	ARZERRA	ofatumumab	Injection	125326	October 26, 2009	9,499,625	2035-03-06
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,499,625

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
South Africa	201203782	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	2011070024	⤷ Get Started Free
United States of America	9879085	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.